表皮/imcDC2轴促进了人类NSCLC中新辅助抗PD-1的抵抗
Yongyuan Chen1,2, Zheyu Shao1,2, Zhixing Hao1,2
1Department of Thoracic Surgery, The Second Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.
Journal for immunotherapy of cancer
|August 12, 2024
概括
在非小细胞肺癌 (NSCLC) 中,新辅助剂抗PD-1 治疗耐药性与抑制CD8+ T细胞的加勒-9+癌细胞有关. 与PD-1一起阻断TIM-3可以通过恢复T细胞功能来克服这种抵抗.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 翻译医学是一种翻译医学.
背景情况:
- 对免疫检查点抑制剂 (ICI) 的治疗耐药性限制了长期益处.
- 在非小细胞肺癌 (NSCLC) 中新辅助剂抗PD-1 耐药性背后的机制尚未完全理解.
研究的目的:
- 阐明NSCLC中新辅助抗PD-1疗法的初级耐药性机制.
- 确定预测对新辅助抗PD-1疗法的反应和耐药性的生物标志物.
- 探索克服抗性的治疗策略.
主要方法:
- 对NSCLC患者样本进行多omics分析 (质量细胞计,scRNA-seq,散装RNA-seq,多色流细胞计).
- 在体外实验中对原始细胞和细胞系进行实验.
- 在体内研究使用易斯携带的小鼠模型.
主要成果:
- 增加的CD8+组织内存T细胞 (TRMs) 与疗效相关;增加的CD1c+未成熟的经典2型树突细胞 (imcDC2) 和加列-9+癌细胞与耐药性相关.
- 一个涉及加勒-9/TIM-3的表皮/imcDC2抑制轴抑制CD8+TRM抗瘤反应.
- CD8+TRMs和加列-9+癌细胞的基因表达预测了临床结果.
结论:
- 加列-9表达瘤细胞通过加列-9/TIM-3通过抑制imcDC2和CD8+TRMs驱动NSCLC中新辅助抗PD-1疗法的初级耐药性.
- 将抗TIM-3与抗PD-1疗法结合起来,可以破坏这种抑制循环并克服抵抗.
相关概念视频
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Cadherins in Tissue Organization
3.0K
The cadherins are a superfamily of cell adhesion molecules comprising over 180 variants, with specific tissues expressing a particular combination of cadherin types. Cadherins generally exhibit homophilic binding; i.e., cadherins on one cell bind to cadherins of the same or closely related type on another cell. Thus, cells of the same type have a specific affinity to bind to each other and sort themselves into clusters to form tissues.
Cell Sorting During Development
Cell sorting plays an...
Cell Sorting During Development
Cell sorting plays an...
3.0K


